Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
DNA Link logo — 경험을 바탕으로 최고를 만듭니다.

DNA Link

경험을 바탕으로 최고를 만듭니다.

Founded 2000 Korea South Korea South 39 employees Venture round Biotechnology, Pharmaceutical

General Information

Company Name DNA Link
Founded Year 2000
Location Korea South Korea South
Employees 39
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with DNA Link. To contact DNA Link, visit dnalink.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DNA Link compare?

A PDF of DNA Link and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DNA Link soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DNA Link

DNA Link is a frontier company in medical genetics research, with a slogan of "Experience-based excellence." The company collaborates with Korea’s most renowned clinical research specialists to study the genetic effects of various diseases, including diabetes, cardiovascular disease, cancer, atopy, and digestive diseases. DNA Link's current research projects utilize advancements in genomic research technology, enabling rapid analysis of whole genomes to identify relationships between diseases and genomic content. Founded in 2000, DNA Link operates in the biotechnology and pharmaceutical industries from its headquarters in Korea South. The company received a Venture Round investment at 01 January 2004 from IMM Investment and Shinhan Venture Investment. In addition to identifying disease-related genes, DNA Link is involved in developing disease diagnostic systems as well as personalized treatment methods. The company utilizes DNA Chip and Next Generation Sequencing technologies to develop cancer diagnostic systems, focusing on identifying common variants in DNA copy numbers for various cancers, including lung cancer and breast cancer. DNA Link's approach of considering the entire human genome to search for potential disease markers marks a significant shift from previous genetic disease studies, which were limited by a finite set of candidate genes targetted for research.

Business keywords: medical genetics research, genomic research technology, disease identification, personalized treatment, DNA Chip, Next Generation Sequencing, cancer diagnostic systems, Sequencing Services, Microarrays, Human Identification, Clinical Diagnostics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
IMM Investment Shinhan Venture Investment
IMM Investment, Shinhan Venture Investment
01 Jan 2004

DNA Link Alternatives & Competitors

View All Alternatives
DNA Link vs
AVESTHAGEN LIMITED
AVESTHAGEN LIMITED India

BRINGING SCIENCE TO LIFE - Convergence of Food Pharma & Population Genetics

Venture round
109 employees
Biotechnology, Health Care
DNA Link vs
LCM Genect
LCM Genect Italy

Enable precision medicine

6 employees
Biopharma, Biotechnology
DNA Link vs
Diatech Pharmacogenetics
Diatech Pharmacogenetics Italy

Leader in the development, production and sales of pharmacogenetics tests for cancer precision medic...

Private Equity
76 employees
Biotechnology, Health Care
View all alternatives

FAQ About DNA Link

경험을 바탕으로 최고를 만듭니다.
DNA Link was founded in 2000.
DNA Link is headquartered in Korea South.
DNA Link operates in Biotechnology and Pharmaceutical. Its work centres on medical genetics research, genomic research technology, disease identification and personalized treatment.
DNA Link has approximately 39 employees.
DNA Link has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to DNA Link include AVESTHAGEN LIMITED, LCM Genect, Diatech Pharmacogenetics, Perlegen Sciences, NeoGenomics Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DNA Link and AVESTHAGEN LIMITED are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DNA Link, https://bouncewatch.com/company/dna-link, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes